While many are concerned with the efficacy of Covid-19 vaccines, The FDA has approved Monoclonal Antibody (mAB) Therapy to treat those who have tested positive and are at high risk. This promising therapy will help this group to battle Covid-19 and recover better. This one-time infusion has been reviewed and results show it can slow or stop the progression of the infection and lessen the need for hospitalization. The links below will offer more information about the therapy.
This therapy is NOT without risks, The National Institute of Health has produced an article about the side effects and use risks.
This new treatment and others will be leading the way to minimize the severity of the Covid-19 virus as well as other health issues.